FNDC5

Fibronectin type III domain-containing protein 5 (FNDC5) is a protein that in humans is encoded by the FNDC5 gene. FNDC5 is a membrane protein that is involved in various biological processes, including the regulation of energy metabolism, inflammation, and insulin sensitivity. It has gained significant attention due to its role in the secretion of irisin, a hormone that is believed to drive the conversion of white fat cells into brown fat cells, thus playing a crucial role in the process of thermogenesis and obesity management.

Structure

FNDC5 is composed of a signal peptide, a fibronectin type III domain, and a hydrophobic region that anchors it to the membrane. The fibronectin type III domain is a common structural motif found in various proteins and is involved in protein-protein interactions.

Function

The primary function of FNDC5 is its role in the secretion of irisin. Irisin is produced when the FNDC5 precursor is cleaved, and it is released into the circulation. Irisin has been shown to have several beneficial effects on metabolic diseases and energy expenditure, making FNDC5 a potential target for the treatment of diabetes, obesity, and other metabolic disorders.

In addition to its metabolic effects, FNDC5/irisin has been implicated in the regulation of neuronal development and cognition, suggesting a broader physiological role beyond metabolism.

Clinical Significance

Research has indicated that FNDC5 and irisin levels are inversely correlated with obesity, type 2 diabetes, and insulin resistance, making it a potential biomarker for these conditions. Furthermore, exercise has been shown to increase the expression of FNDC5, thereby elevating irisin levels, which contributes to the health benefits associated with physical activity.

Research Directions

Ongoing research is focused on elucidating the detailed mechanisms of action of FNDC5 and irisin, their potential therapeutic applications in metabolic diseases, and their role in other physiological processes. The development of drugs that can modulate the activity of FNDC5 or the levels of irisin represents a promising avenue for the treatment of metabolic disorders.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian